“These autism/neurodevelopmental disorder patents make claim for NNZ-2591 producing an improvement in one or more of a wide range of symptoms, including many of those being assessed in the current Phase 2 trials.”
Truly great post; I’ll guarantee that 90% of holders here or the stock in general didn’t realize the above, thanks again Hottod for all your research.
Phase 2, page-3
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.21 |
Change
0.270(2.09%) |
Mkt cap ! $1.682B | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.35 | $13.02 | $3.057M | 231.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 92 | $13.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.23 | 652 | 8 |
View Market Depth
| Last trade - 14.07pm 14/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |